This week, our focus is on two critical tests: AMA (Anti-Mitochondrial Antibodies) and ASMA (Anti-Smooth Muscle Antibodies). These tests are essential in diagnosing various autoimmune conditions, including Primary Biliary Cholangitis and Autoimmune Hepatitis, which can significantly impact liver health.
By conducting these tests, we are ultimately helping patients get diagnosed faster, ensuring they receive the care they need without delay. Using Immunofluorescence Testing (IFT), we ensure high accuracy and reliability in our results, which is crucial for guiding effective treatment plans.